In vitro studies have demonstrated that humanin functions against Alzheimer disease related insults to the cell, moreover, IGFBP-3 has been demonstrated to be increased in Alzheimer’s disease (Rensink et al., 2002). This evidence concerns the gene MT-RNR2 and early-onset autosomal dominant Alzheimer disease.